| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  SCK CEN Exploring a better tomorrow Do not underestimate the power of atoms: nuclear applications can make a great difference for society both now and in the future. This is why as one of the biggest research centres in Belgium we continue to perform groundbreaking research. SCK CEN is a global leader in the field of nuclear research, services and education. With more than 900 employees, throughout all of our work, we are focusing on 6 research topics: • Health • Environment • Society • Materials • Technology • Safety These are our building blocks for developing innovative applications for society. In … Type: | 4 | 4 | 0 | 843 |
 | PMV [Automatic translation follows] Financing solutions for every promising company or project with a good business plan PMV is a Flemish investment company that invests in the future of the Flemish economy. We finance promising companies and projects from the very beginning to growth and internationalization. In addition, we provide financial customization for all entrepreneurs with a sound plan and a good team. To this end, our one hundred and twenty-five professional employees draw on our proven arsenal of capital, loans and guarantees. With more than one billion euros in assets to invest, we are a powerful investment company that fully … Type: | 13 | 8 | 7 | 996 |
 | Olivier Millet [Automatic translation follows] Member of the Executive Board @Eurazeo, @Eurrazeopme, Member of Ca @Europlace, Ex Mer Executive Committee @medef, former president @franceinveteu #privateequity #PME #ETI #esg | 6 | 1 | 3 | 28 |
 | Provence Angels [Automatic translation follows] Investing and getting involved alongside entrepreneurs Provence Business Angels is an association (1901 law) that was created in September 2007. The network brings together around fifty members with diverse profiles in terms of qualifications and experience. Most of the members have a background as entrepreneurs or senior executives. They now want to use their experience to support the start-up of young companies. Provence Business Angels mainly finances and supports companies with high growth potential. Its action helps support the regional economy and job creation. Provence Business Angels intervenes in companies at the seed stage, i.e. at a … Type: | 52 | 7 | 48 | 35 |
 | Stilla Technologies Discover the Sensitivity & Simplicity of Multiplex Crystal Digital PCRTM Stilla Technologies is a leading global biotechnology company that focuses on accelerating development of next-generation genetic testing by providing researchers and clinicians with a flexible Digital PCR solution for high-resolution genetic analysis and assay development. Stilla’s next-generation Multiplex Crystal Digital PCRTM technology employs cutting-edge microfluidic innovations and integrates the entire dPCR process on a single chip. The naica® system is highly sensitive, fast, and features an easy workflow, higher levels of multiplexing, and intuitive software. Stilla developed the world's first 6-color Digital PCR Platform, providing High Multiplexing and Sensitivity for … Type: | 7 | 2 | 4 | 104 |
 | KLODIOS The collective intelligence platform in healthcare ❔ KLODIOS is a platform which, thanks to its AI, gathers in one place and suggests news, knowledge in health in a simple, fast and secure way. We are convinced that all health professionals - health authorities, industry, associations - deserve a space to share information. ❕ Every day, caregivers face a multiplicity of sources to find answers, they lose time. This time is not devoted to patients. 💬 We firmly believe in collective intelligence, in a community and interdisciplinary approach to health. 🩺 KLODIOS is the collective intelligence platform in health. santé, information, … Type: | 19 | 3 | 17 | 4 |
 | Voxdale | design-driven engineering Specialized in design-driven engineering services that ensure manufacturability and product success. Introducing Voxdale: your product development partner for success and innovation. In today’s competitive market, your hardware challenges need bold, innovative, and high-performing solutions. That’s where we come in. At Voxdale, we’ve spent nearly two decades designing and developing products to meet the specific business and consumer needs of start-ups, scale-ups, and multinational companies. Our creative team of experts, designers, and engineers will put your ideas through state-of-the-art simulations and prototyping to accelerate their development. The end result? Products that wow. With Voxdale on your team, you’ll be supported at … Type: | 8 | 0 | 8 | 40 |
 |  Amolyt Pharma Advancing peptides for the treatment of rare endocrine and related diseases Amolyt Pharma is building on its team’s established expertise to deliver life-changing treatments to patients suffering from rare endocrine and related diseases. Amolyt Pharma’s portfolio includes eneboparatide (AZP-3601), a long-acting PTH1 receptor agonist as a potential treatment for hypoparathyroidism, and AZP-3813, a peptide growth hormone receptor antagonist for the potential treatment of acromegaly. Amolyt Pharma aims to further expand and develop its portfolio by leveraging its global network in the field of endocrinology and with support from a strong syndicate of international investors. Hypoparathyroidism, Endocrinology, Metabolic Disease, Therapeutic Peptides, … Tags: FrenchTech2030 Type: | 11 | 10 | 1 | 54 |
 | DNA Script Transforming how molecular biology translates to human health, personalized medicine and synthetic biology DNA Script was created to revolutionize DNA synthesis with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. The integration of these innovations has resulted in SYNTAXTM️, the world’s first benchtop DNA printer powered by enzymatic technology. With continued advancement and innovation, we believe DNA Script’s enzymatic DNA synthesis technology is poised to become the engine of genomics research and personalized medicine. Synthetic Biology, Biotechnology, DNA synthesis, Sciences, Research, Development, Start-up, and Technology Tags: FrenchTech120 FrenchTech2030 Type: | 36 | 13 | 25 | 186 |
 | Casdin Capital, LLC Life Science Investments Casdin Capital, LLC is a New York-based research investment firm focused on the innovations in molecular medicine currently reshaping Life Sciences and healthcare. Founded in 2011, and with an eye to long-term returns and disruptive technologies, Casdin Capital is an expert working with experts, benefiting from its position at the crossroads of the science and investment communities. As trusted investor-partners in both private and public companies, we collaborate with industry leaders to fuel their visions, adding energy, insight, and experience to our over $2.4 billion under management. As we push into new markets and new developments, we … Type: | 6 | 2 | 0 | 53 |
 | UI Investissement [Automatic translation follows] Together, investing for a better future A specialist in the development of unlisted French companies, UI has been committed and invested for over 50 years alongside managers of startups, SMEs and growing mid-cap companies to help economically and sustainably successful companies emerge and develop. UI Investissement manages around €1.5 billion in assets and invests with 300 managers in sectors that are essential to society, such as health, agribusiness, industry and services. Development and transmission capital, the historical core of UI's activity, represents over half of the assets under management and allows over 50 companies to benefit from … Type: | 107 | 47 | 46 | 111 |
 | IPEM Meaningful Connections for Private Markets IPEM Paris 2024 | September 9, 10 & 11, Palais des Congrès, Paris, France. IPEM, International Private Equity Market, is the premier relationship broker for global private equity. It brings together the entire private equity ecosystem, facilitating connections and knowledge-sharing through a range of channels. Attendees can connect in person at events such as exhibitions, networking sessions, and conferences, and stay informed throughout the year via the IPEM website and LinkedIn page. Additionally, the IPEM platform offers access to exclusive reports and online services such as pre-networking and matchmaking recommendations. In only 8 years, IPEM … Type: | 63 | 37 | 32 | 115 |
 | Andrew Lloyd & Associates International PR group | Market communications for life sciences & tech 🚀 Andrew Lloyd & Associates is an international public relations consulting group for leading edge companies and organizations involved in emerging technologies. ALA has its own offices in the United Kingdom and France, as well as a network of collaborators, individuals and companies, throughout Europe and the US. ALA has been active across Europe since 1987 and has the experience and know-how to provide seamless and scalable services in one or many EU countries and the US Andrew Lloyd & Associates is active in technical, business, financial and scientific … Type: | 50 | 3 | 47 | 10 |
 | Paris-Saclay SPRING May 12,13, 2022 | Come & discover Europe’s Number 1️ INNOVATION ECOSYSTEM! Produced in partnership with @VivaTech All those involved in innovation, research, science and economic development have come together, one more time, to cast a spotlight on the technological innovations and scientific achievements that are made here every day. Accounting for 40% of public research and private R&D undertaken in Ile-de-France, the Paris-Saclay innovation cluster is undoubtedly at the forefront of French innovation. Innovation, FoodTech, GreenTech , Mobilités, Santé-Biotech , and Technologies Numériques Type: | 78 | 27 | 65 | 1 |
 | INNOVACOM Accélérer les transitions environnementale, numérique et industrielle. Innovacom has invested 1 billion Euros in hundreds of technological and industrial start-ups. Through venture and seed Funds, Innovacom is an active investor, working with some of the brightest minds in the business, focused on delivering new technologies, hardware and software products, services and content to corporations or consumers. With a deep international background, we are uniquely positioned to help our portfolio companies not only with capital, but with access to the best partners and customers. Innovacom is part of Turenne Groupe. #deeptech #industry #Frenchtech #startup #innovation Early Stage Venture Capital and Late … Type: | 61 | 25 | 31 | 18 |
 | Supernova Invest European deeptech VC, focused on high-growing start-ups and cutting-edge technologies Supernova Invest is a European multi-stage VC firm with currently €800m AUM. Our team provides unparalleled expertise and patient capital in the fields of Digital, Industrial Technologies, Healthcare and Cleantech to support high-growth, deeptech start-ups and scale them globally. We support disruptive tech companies such as Soitec, Ynsect, Alice & Bob, Gleamer, Prophesee, Crowdsec, UnitySC or Unseenlabs. The Supernova team exited +25 companies through top IPO and M&A deals. The team is composed of +20 experienced investors with a unique ability to understand both the underlying technologies and the most … Type: | 61 | 19 | 44 | 35 |
 | Hi Inov - Dentressangle Hands-on venture capital from entrepreneurs to entrepreneurs Hi Inov is a European B2B fund made by entrepreneurs for entrepreneurs and based in Paris, Lyon and Munich. We support outstanding hypergrowth companies who transform the ever-changing services and industrial landscape with their innovative digital deep-tech technologies. Our highly experienced venture team will guide you from your humble beginnings to becoming tomorrow's industry category leaders. Backed by a strong network of potential clients, partners and experienced advisors, we will not only help you become champions on your home market, but also quickly open the doors to the French and German markets and … Type: | 55 | 6 | 50 | 17 |
 | Newfund This is where exceptional entrepreneurs get stronger Started in 2008 by and for founders, Newfund Capital is an early-stage VC firm active in France and in the USA. It has developed a strong culture centered around entrepreneurship and encourages initiatives to support the ambitions and the development of its portfolio companies. Newfund has $300 million in AUM subscribed mostly by entrepreneurs and family offices. Newfund's investment strategy is people-driven, focused on the constant search of entrepreneurs obsessed to realize their vision. We seek to understand entrepreneurs as individuals, appreciate their originality and play to their strengths. Greatness comes in all … Type: | 55 | 21 | 37 | 46 |
 | Angels Santé The leading European Business Angels network in healthcare investment Europe’s number one Business Angel Network for Health Angles Santé investors provide their funds and expertise to start-ups with strong potential to support their launch and development. Our mission at Angels Santé: to detect European start-ups that meet the challenges of our health systems with economically responsible solutions and strong medical benefits, to boost seed-stage development by providing direct capital, expertise and networks, to mobilize non-specialized investors towards health investment to meet the needs of ambitious projects. Our members invest in healthcare projects that they understand, thanks to their expertise and … Type: | 64 | 12 | 49 | 74 |
 | EntendsMoi [Automatic translation follows] Thanks to VERBATIM.Care, act on the improvement of practices thanks to the continuous analysis of the patient experience Co-founded by expert patients, healthcare professionals and an engineer, EntendsMoi built its first digital solution VERBATIM.care in co-development with 9 healthcare establishments (CHU, GHT, ESPIC, Clinic, Cancer Center). Now deployed in more than 50 establishments in France and Belgium to act on the improvement of professional and organizational practices thanks to the lived experience of patients, collected in their free comments. The words of patients are transformed into levers of action thanks to Automatic Language Processing (TAL) and allows … Type: | 25 | 6 | 22 | 5 |
 | Protéines France Association œuvrant pour le développement du secteur des protéines végétales et des nouvelles ressources Protéines France is the French consortium of enterprises whose ambition is to federate and catalyse the development of innovative. Protéines France aims to speed up the development of the plant-based and alternative protein sector in order to seize the opportunities for growth and job creation offered by the global increase in the demand for proteins and thus to make France a world protein leader. PROTEINES FRANCE *We focus on innovative proteins: plant-based and alternative sources (insects, algae, microorganisms...) *We bring together the major French innovative proteins … Type: | 39 | 4 | 39 | 3 |
 |  Villa M - Paris [Automatic translation follows] Villa M is a unique concept-place in the world dedicated to the health of tomorrow, in the heart of the 15th arrondissement of Paris. This holistic haven was created by Groupe Pasteur Mutualité for all health professionals and for all those who make their health and well-being a priority. It brings together a prevention center, a boxing & fitness club, a sports-health center, meeting rooms, an innovation showroom and concept store, a hotel and a restaurant. Villa M is a place of sharing, discovery and meetings for all stakeholders in responsible, civic and universal health: professionals, researchers, … Type: | 11 | 3 | 8 | 46 |
 | Sensome Sensitive Medical Devices Sensome is an innovative start-up developing a breakthrough sensing technology that can turn invasive medical devices into connected healthcare devices. Sensome is EN ISO 13485:2016 certified. Medical Devices, Connected Objects, MedTech, and Neurovascular Type: | 11 | 6 | 6 | 38 |
 | Health Innovation Port [Automatic translation follows] ...where health startups and relevant stakeholders from the healthcare sector come together to shape the future. We are a collaboration space, incubator, accelerator, community, knowledge platform We focus on collaboration rather than competition in the middle of Hamburg. This is where startups from the healthcare sector and established players in the healthcare industry come together to shape the future of healthcare together. Our goal? Interwoven in a strong partner network, we want to create a place where innovative ideas and new business models can develop and grow in the digital health market. What do we offer? In … Type: | 5 | 1 | 5 | 2 |
 | EuroQuity - Bpifrance Shine Match & Deal EuroQuity is a service by Bpifrance, France's national investment bank, financing businesses through loans, guarantees, equity investments, and export insurances. Created in 2008, EuroQuity is an online matchmaking platform that helps companies meet investors and partners. EuroQuity is one of the leading matchmaking platforms in Europe while becoming increasingly present in Africa. We provide many additional services such as acceleration programs funded by the European Commission, digital training, coaching sessions, and exclusive online pitch sessions for the most promising companies. In short, EuroQuity is the perfect match for companies to scale with confidence and speed and … Type: | 44 | 7 | 21 | 3 |
 | Omnidoc [Automatic translation follows] The tele-expertise platform that facilitates and enhances medical collaboration Omnidoc is a tele-expertise solution for private doctors and healthcare institutions. Omnidoc makes it possible to secure, track and financially enhance the opinions exchanged between doctors. It offers the opportunity to better sort and prioritize requests for care, to strengthen links between correspondents or city / hospital and to improve the patient care pathway. Type: | 6 | 1 | 3 | 33 |
 | Sambrinvest We are the leading venture capital in Charleroi Metropole Sambrinvest est un acteur privé de capital à risque actif dans la région de Charleroi Métropole. Il a pour objet l'accompagnement et le développement des PME et des startups. Par son expertise, il conseille les entrepreneurs, à chaque stade de développement de leurs projets, tout en respectant leur autonomie de gestion. Venture Capital, SME, Startups, Investments, Equity, Loan, Risk Investments, and Hainaut Type: | 15 | 3 | 15 | 37 |
 | Andera Partners The Power of And Created over 20 years ago, Andera Partners is a major player in private company investments in France and internationally. Its teams manage over €3.6 billion in investments in life sciences (Andera Life Sciences), growth and buyout capital (Andera MidCap, Andera Expansion, Andera Croissance, Andera Co-Invest), sponsorless transactions (Andera Acto) and ecological transition (Andera Infra). Andera Partners’ mission is to work alongside companies and their managers to support them in achieving strong and sustainable growth. The quality of performance offered to our investors relies on a strong partnership between the entrepreneurs in our portfolio companies and our … Type: | 35 | 20 | 19 | 128 |
 | In Extenso [Automatic translation follows] Undertake the Future. / Great Place to Work Certified Created in 1991, In Extenso is one of the leaders in accounting expertise in France. With a network of 250 locations across France, In Extenso offers business leaders, artisans, traders, liberal professions and association managers a local service covering all accounting, administrative, legal, tax and social aspects of their organization. A multidisciplinary firm, In Extenso also offers services in mergers and acquisitions (In Extenso Finances & Transmissions), consulting in Tourism Culture Hospitality (In Extenso Tourisme Culture Hôtellerie), wealth management (In Extenso Patrimoine), consulting for innovative organizations (In Extenso … Type: | 105 | 46 | 6 | 3,661 |
 | Artefact We are a global leader in data transformation services and data marketing to drive business value across organizations. Artefact is a leading global consulting company dedicated to accelerating the adoption of data and AI to positively impact people and organizations. We specialize in data transformation and data marketing to drive tangible business results across the entire enterprise value chain. Our 1500 employees operate in 23 countries (Europe, Americas, Asia, Middle East Africa) and we partner with 1000 clients, including 300 major brands like Samsung, L’Oréal, Orange and Sanofi. We provide customized services from strategy to operations: data strategy, data quality … Type: | 80 | 11 | 73 | 1,769 |
 | Tacalyx GmbH Tacalyx develops the next generation of anti-Cancer therapeutics in indications with high medical need Type: | 3 | 0 | 3 | 13 |
 | SciRhom Targeting iRhom2 for better treatment of autoimmune diseases SciRhom GmbH, based in IZB Martinsried, Germany, is a biotech start-up company that translates science into the preclinical and early clinical development of novel biopharmaceuticals for the treatment of life-threatening diseases. Founded in late 2016, we develop first-in-class antibodies against iRhom2, a key modulator of several crucial pro-inflammatory signalling pathways, including TNF-alpha signalling. Following the preclinical and early clinical development of these monoclonal antibodies, we are aiming to provide superior treatment options to currently existing inhibitors of TNF-alpha signaling. SciRhom is poised to transform the lives of patients with autoimmune diseases. drug … Type: | 2 | 1 | 2 | 15 |
 | Poppins Health and reeducation through music 🎶 Mila is an early-stage social technology venture focused on helping through music. Our flagship product is a rehabilitation tool for learning and language disabilities that we develop in collaboration with speech therapists and neurologists. For this purpose, we create awesome technology to deliver a personalized and effective musical activity experience. Not just listening to sound: also activities, exercises, and interactions. Software design, Neuroscience, Music, Learning disabilities, Adaptative Learning, Data sciences, Health, Education, and Dyslexia | 24 | 8 | 17 | 48 |
 | Dynacure Dynacure is a clinical-stage company focused on developing novel therapies for rare diseases. Dynacure is a clinical-stage company focused on developing and commercializing novel therapies to transform the lives of patients with rare diseases who have limited or no treatment options. Dynacure is developing DYN101, an investigational antisense product candidate designed to reduce the expression of dynamin 2 protein for the treatment of Myotubular and Centronuclear Myopathies, in strategic collaboration with Ionis Pharmaceuticals. Dynacure is also building a complementary research portfolio targeting other orphan disorders, including its DYN201 program for the treatment of Hereditary Spastic Paraplegias. Dynacure is headquartered in … Type: | 6 | 5 | 2 | 11 |
 | ImCheck Therapeutics Bringing a novel class of Butyrophilin-targeted checkpoint modulators into the clinic ImCheck Therapeutics is designing and developing a new generation of immunotherapeutic antibodies targeting butyrophilins, a novel super-family of immunomodulators. As demonstrated by lead clinical-stage program ICT01, which has a mechanism of action to simultaneously modulate innate and adaptive immunity, ImCheck's “first-in-class” activating antibodies may be able to produce superior clinical results as compared to the first-generation of immune checkpoint inhibitors and, when used in combination, to overcome resistance to this group of agents. In addition, ImCheck’s antagonist antibodies are being evaluated as potential treatments for a range of autoimmune … Tags: FrenchTech120 FrenchTech2030 Type: | 29 | 13 | 19 | 54 |
 | Alpha Intelligence Capital Alpha Intelligence Capital (AIC) is an entrepreneurs-led, entrepreneurs-invested, global closed-end private venture capital fund. We invest in Seed to Series B, deep Artificial Intelligence/Machine Learning (AI/ML) technology-based companies. We invest in teams applying deep expertise in the algorithmic sciences to develop breakthrough products and solve real business problems. AI, Artificial Intelligence, Venture Capital, Fund, Partnership, Machine Learning, Deep Learning, Investment, Deep Learning, Computer Vision, Cyber Risk, Robotics Automation, ASICs, Reinforcement Learning, and Quantum Computing Type: | 17 | 4 | 13 | 19 |
 | NaoX Technologies [Automatic translation follows] A laboratory in the ear NaoX Technologies is a French startup launched in 2018 by Hugo DINH, Polytechnician and Michel LE VAN QUYEN, expert in neuroscience at Inserm. Our mission is to democratize the prevention of neurological disorders. Neuroscience, IOT, and Health & Well-being Type: | 20 | 3 | 18 | 21 |
 | Orakl Oncology Orakl Oncology integrates best-in-class biology with high-quality patient data to transform oncology drug development. Orakl Oncology leverages a unique collection of patient tumor avatars that combines biology and clinical data to fuel the therapeutic arsenal to fight cancer. With our platform we partner with oncology players to identify relevant targets and deliver new drugs, faster. Type: | 20 | 8 | 15 | 11 |
 | AI for Health We connect public and private actors in the Artificial Intelligence and the Healthcare Industry AI for Health's mission is to bring together the ecosystems of Artificial Intelligence and Health to support the ambition of the national strategy for Artificial Intelligence inHealth. It is essential to invest and mobilize now, in order to fully seize the opportunities that Artificial Intelligence offers to revolutionize the health sector." These future opportunities are clear: to increase access to care, quality of life and healthy life expectancy for the world's population. This will only be possible if the world of health opens up to other … Type: | 61 | 5 | 51 | 10 |
 | Hy24 Hy24 is the world's first investment manager fully dedicated to scaling up the clean hydrogen economy. Hy24 is a joint venture between Ardian, Europe’s largest private investment house with managed assets of c. $164 billion, and FiveT Hydrogen, the first pure-play low-carbon hydrogen private investment and asset management platform. We combine Ardian’s premier infrastructure fund management record with FiveT’s unparalleled hydrogen expertise and network. We will scale up the global hydrogen economy through first-mover investment opportunities perfectly aligned with the universal ESG agenda. clean hydrogen, infrastructure, industry, mobility, hydrogen economy, asset management, finance , and ESG Type: | 57 | 12 | 52 | 45 |
 | Leavy.co Live Anywhere Founded in 2017 & launched in 2018, Leavy.co is a young French scale-up already spotted as Europe’s answer to Airbnb. On a clear mission to unlock travel for everyone, our platform gets straight to the point: we pay directly, in advance & within 24 hours, users willing to share their homes or care for fellow travellers. Within 18 months, we opened offices in Paris, Amsterdam, London, Madrid, Rome, and Lisbon. Today we are active in 83 cities! Join Leavy today, travel the world with us and bring your next trip a little closer! Travel, Mobility, Community, DeepTech, Marketplace, … Type: | 10 | 0 | 10 | 21 |
 | EBD Type: | 27 | 4 | 19 | 149 |
 | Solence [Automatic translation follows] The mobile application that helps women live better with PCOS I Understand your symptoms. Adapt your lifestyle. Solence is a French healthtech whose mission is to improve the management of chronic diseases affecting women by offering digital medical solutions leveraging lifestyle medicine and behavioral sciences. Solence's first mobile application is intended for women with polycystic ovary syndrome, a hormonal and metabolic disease that affects 1 in 7 women and is the leading cause of female infertility in the world. While there is no curative treatment, Solence offers a solution to support the management of PCOS symptoms by … Type: | 14 | 2 | 9 | 4 |
 | SpainCap [Automatic translation follows] Capital for a Sustainable Future SpainCap is the association that brings together Venture Capital & Private Equity entities in Spain, as well as their investors, including insurance companies and pension funds. SpainCap members invest in the medium and long term in unlisted companies, from start-ups to consolidated companies, providing not only stable financing through capital, but also innovation and support in management. The mission of the employers' association is to connect all the actors in the industry in Spain, representing their interests before the Administration, the media and public opinion, both nationally and internationally, through alliances and … Type: | 22 | 7 | 14 | 15 |
 | Raidium Raidium foundation model : Radiology augmented GPT to tackle the complexity of precision medicine Build the first Radiological Foundation Model Bring the radiological image to GPT Share the world's top medical expertise through AI Bring the best specialist to every patient/researcher/company artificial intelligence, radiology, medical imaging, and foundation model Type: | 11 | 3 | 5 | 16 |
 | Charles.co [Automatic translation follows] Charles is a Digital Clinic that helps its patients solve their chronic problems (sex, sleep, hair) Charles helps you regain control over your daily health concerns starting with intimate health, sleep disorders, hair loss and soon digestive problems. Men's Health, Health, and Digital Health Type: | 3 | 2 | 2 | 18 |
 | Ysios Capital Backing the breakthroughs of tomorrow Ysios Capital, a leading Spanish venture capital firm, provides private equity financing to early and mid-stage life science companies that develop disruptive therapeutic products and platform technologies. Founded in 2008, Ysios Capital manages over USD 420M through three dedicated funds in life sciences and is led by a team of professionals experienced in building biotech companies. Venture capital and biotechnology Type: | 7 | 2 | 5 | 25 |
 | Asabys Partners Investing in Life. Investing in Science. Investing in Future. Asabys Partners is a venture capital firm from Barcelona investing across the board in human healthcare. We are active in the health-tech and biopharma industries and aim to invest in Spain and abroad in highly innovative and transformative technologies. We are motivated by the idea of pushing the boundaries of science and medicine. We do this through the sourcing and financing of the most disruptive technologies, and through the collaboration with the best internal and external talents of our industry. We have an entrepreneurial spirit and seek to be involved in … Type: | 20 | 3 | 17 | 12 |
 | Inserm Transfert Votre partenaire en valorisation spécialisé dans le transfert de technologies en santé humaine et sciences de la vie Inserm Transfert is the Inserm subsidiary dedicated to value creation and technology transfert in lifescience and human health. Inserm Transfert, the private subsidiary of the French National Institute of the Health and Medical Research (Inserm), is responsible for value creation of Inserm innovations in human health and promotes long-term technology transfers in line with international best practices. Inserm Transfert SA was founded in 2000, and manages, under a Public Service Management Contract (Délégation de Service Public), the entire promotion and transfer of … Type: | 72 | 29 | 53 | 119 |
 | Institut Imagine Institut Imagine, pour guérir les maladies génétiques. Institut Imagine for genetic disease is a French translational research institute which performs state-of-the-art research in order to better understand genetic diseases. The Institute brings together scientists and physicians around the patients in a unique, ultra-modern 19,000 sqm building located within Necker Children’s Hospital, Paris. The teams also benefit from cutting-edge technological platforms and clinical facilities providing methodological advice as well as huge and rationalized cohorts of patients. The objective is to foster translational research and accelerate the development of new therapeutic and diagnostic solutions for the ultimate benefit of the patients and … Type: | 47 | 18 | 34 | 416 |
 | Groupe Pasteur Mutualité [Automatic translation follows] FOR US, HEALTHCARE PROFESSIONALS. A leading mutual insurance and services group managed for over 160 years by and for healthcare professionals, Groupe Pasteur Mutualité is committed to its members, from the start of their studies, to provide them with solutions that are perfectly suited to their professional and private lives. The Group places innovation, prevention and solidarity at the heart of its development project. Since 2021, its "Villa M" program has welcomed the entire community of healthcare professionals and all visitors wishing to learn, exchange, discover, pilot and test the latest healthcare innovations in the heart of … Type: | 18 | 3 | 11 | 404 |
 | Spotlight Medical A precision medicine company solving the critical issue of inadequate cancer treatments Spotlight Medical is a precision medicine company striving to free all patients from cancer through a better understanding of each patient’s unique disease. We develop advanced AI tests that enhance treatment selection by leveraging decades of patient data. This ensures personalized and effective care for each individual, significantly improving patient outcomes and quality of life. By closely collaborating with physicians, we create impactful tests that address critical unmet clinical needs, opening a new era in cancer care. Founded in 2024, Spotlight Medical is backed by Institut Curie and … Type: | 4 | 3 | 3 | 4 |
 | Start West [Automatic translation follows] ⭐️ The most promising innovative companies of the moment present themselves to investors 💸 Start West is the annual meeting of investors and innovative entrepreneurs in the West. For a day and an evening, they can meet to make contacts or to do business. entrepreneurship, investment, and startup Type: | 22 | 11 | 18 | N/A |
 | Mines Paris - PSL [Automatic translation follows] Since its creation 240 years ago, Mines Paris – PSL has been training engineers and producing essential knowledge to help companies meet the challenges of their time. Originally those of mining for the production of energy necessary for large-scale industrialization, today those of ecological transitions and digital transformations. A founding member of PSL University, Mines Paris – PSL is a leading French engineering school and the first in terms of partnership research. Type: | 45 | 6 | 42 | 1,023 |
 | SmartCatch For a reliable liquid biopsy accessible to everyone Precision medicine is the adaptation of a medical treatment to the exact molecular profile of each patient. More generally, it relies on the sophisticated analysis of circulating biomarkers (genetic, protein or cellular) in the blood flow of patients. SmartCatch arises from a research work initiated in 2012 by a team of multidisciplinary scientists from the Laboratory of Analysis and Architecture of Systems (LAAS, CNRS) and urologist surgeons of the IUCT-Oncopole and Toulouse hospital. The results of this work have been patented in February 2015. Carried by four of its inventors, SmartCatch was … Type: | 16 | 5 | 13 | 20 |
 | Invyo Europe's leading data platform for data-driven investors (Venture Capital / Private Equity / Family Office) Since 2018, INVYO has been the trusted partner for investors in private equity, venture capital and family offices. We are a reference platform in Europe, propelling investors towards a data and tech-driven investment model thanks to AI. Our sector expertise harnesses your data to boost your human and financial performance. - French publisher - More than 50 client funds - 16 data experts - 2 offices: Paris & Madrid - SaaS solutions Our mission : At INVYO, we unleash the potential of investment teams through … Type: | 71 | 4 | 71 | 21 |
 | Kiro Artificial intelligence serving clinical biology Kiro is a fast-moving startup developing solutions for better patient care, powered by artificial intelligence. We aim at improving everyone’s health by supporting patients and doctors with understandable and relevant information. We believe that medical biology is at the heart of healthcare. It contributes greatly to the diagnosis, treatment and prevention of diseases. Our mission is to foster the interactions between laboratories, health professionals and patients, to go beyond results in patient care thanks to new technologies and artificial intelligence. Since its inception, Kiro has worked in close partnership with clinical biologists, doctors and medical … Tags: FrenchTech2030 Type: | 33 | 11 | 22 | 57 |
 | Wellington Partners Wellington Partners is one of the most successful pan-European venture capital firms. With funds totalling over € 800 million, we have invested throughout Europe in companies that have the potential to become real market leaders for more than 15 years. We are committed to providing outstanding entrepreneurs with the necessary resources to fund their strategies. We typically lead financing rounds ranging from € 0.5 million to € 20 million. Depending on the maturity of the company, our own commitment can go as high as € 15 million. Providing funding is only one part of our business. After funding, the entrepreneurs … Type: | 4 | 4 | 0 | 36 |
 | Fountain Healthcare Partners Fountain Healthcare Partners is a life science venture capital firm based in Dublin Ireland with an office in New York. Fountain currently manages over €300M and is actively investing its third fund raised in 2019. The team at Fountain originally worked within the corporate VC group at Elan Corporation and raised its first independent fund in 2008. Fountain invests in drugs, devices and diagnostics with a focus on companies developing innovative products that address unmet medical needs and deliver significant pharmacoeconomic benefits. Venture Capital, Life Sciences, Medical Devices, Drug Delivery, Pharmaceuticals, Diagnostics, Speciality Pharma, and Biotechnology Type: | 10 | 1 | 4 | 10 |
 | Paladin Capital Group Paladin is a global investor that supports and grows the world’s most innovative cyber companies. Paladin Capital Group is a leading global investor that supports and grows the world’s most innovative companies through venture investment, expansion, and growth capital. We are headquartered in Washington, DC, with offices in London, Luxembourg, New York City, and Silicon Valley. We seek out diverse investment opportunities across the US and worldwide. Paladin is a leader in investing in technologies, products, and services focused on dual use in both commercial and governmental markets with a strong value-add culture. Paladin Cyber Fund: Our most recent fund … Type: | 9 | 1 | 8 | 58 |
 | Memo Therapeutics AG Memo Therapeutics AG (“MTx”) is a late-stage biotech company translating unique human immune responses into superior medicines through the development of best-in-class antibodies to treat viral infections and cancer. The Company’s lead program, Potravitug, is in Phase II development targeting BK viremia (BKV) in kidney transplant recipients, an infection which can result in decreased kidney functionality and longevity and reduced patient survival. Potravitug has the potential to become the best and first-in-class BKV disease-modifying therapy for kidney transplant patients. Alongside Potravitug, MTx is focused on discovering novel antibody-target pairs for oncology based on tumor infiltrating B-cells derived leveraging tertiary lymphoid … Type: | 2 | 1 | 2 | 37 |
 | 2CFinance [Automatic translation follows] Independent financial consulting firm, specializing in Transaction Services and Part Time DAF Our mission: "Advise investors and managers to diagnose and improve the quality and performance of corporate financial departments". • Consulting firm, based in Paris 9th, Aix-en-Provence and Nantes. • Two professions: delegated operational financial management and financial consulting. • A team of 50 employees. • More than 500 missions conducted in Small and MidCap companies, respecting absolute discretion and confidentiality. • A portfolio of renowned entrepreneurs, managers and investment funds. • Long experience in supporting companies in different key phases of their development (start-up, growth, … | 50 | 11 | 44 | 102 |
 | Gilde Healthcare Specialized healthcare investor in both Healthcare Venture & Growth as well as Healthcare Private Equity, managing €2.5B Gilde Healthcare is a specialized European healthcare investor managing two business lines: a lower mid-market buy-out fund and a venture & growth capital fund. Gilde Healthcare's lower mid-market buy-out fund invests in profitable European healthcare services companies with a focus on the Netherlands, Belgium and Germany. The portfolio consists of healthcare providers, suppliers of medical products and other service providers in the healthcare market. Gilde Healthcare's venture & growth capital fund invests in medtech, diagnostics, digital health and therapeutics. The portfolio companies are … Type: | 5 | 3 | 2 | 63 |
 | Verve Ventures Investing in technology and science-driven startups. Adding value through our exclusive network of investors. Verve Ventures is a network and technology-driven venture capital firm headquartered in Switzerland. Founded in 2010, Verve Ventures has grown to more than 45 team members and has become one of the most active venture investors in Europe with over 140 technology and science-driven startups in its portfolio. A dozen investment professionals identify the most promising digital, tangible, and health & bio startups. Verve Ventures provides its pan-European network of selected private and institutional investors access to those top-tier investment opportunities. The company invests from EUR … Type: | 13 | 5 | 8 | 84 |
 | BNP Paribas Fortis Ready for your world 🌍 At BNP Paribas Fortis, we strive to be a trusted financial companion for all our customers. No matter how big or small their dreams and challenges, we are there to help. As the go-to source for all things banking, our customers can count on us for reliable guidance. We are ready to help them make the right choices to achieve their goals. At BNP Paribas Fortis, we are ready for your world. Financial Services and Banking Type: | 24 | 11 | 8 | 13,561 |
 | BNP Paribas Développement [Automatic translation follows] The Trusted Investor BNP Paribas Développement, an autonomous subsidiary of the international banking group BNP Paribas, is a public limited company that directly invests its own funds to support the development of successful SMEs and ETIs and ensure their sustainability by facilitating their transfer, as a minority shareholder. Venture Capital, Shareholding, Transmission, Innovation, Manager, Investment, and Equity Type: | 46 | 28 | 9 | 58 |
 | Kwit Be sure to never smoke again! We believe people can live longer, healthier and happier 🍀 Kwit is one of the leading smoking cessation mobile apps. It relies on evidence-based smoking cessation scientific methods and helps you on a daily basis with positivity and kindness. mobileapp, health, smokingcessation, wellbeing, healthtech, wellness, and mhealth Type: | 43 | 10 | 24 | 17 |
 | TreeFrog Therapeutics Cell Therapy for All TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients. TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality. Bringing together over 70 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M over the past 3 years to advance its pipeline of stem cell-based therapies in the field of neurodegeneration, cardio-metabolic disorders, and immuno-oncology. In 2022, the company will open technological … Tags: FrenchTech120 FrenchTech2030 Type: | 38 | 15 | 26 | 145 |
 | Ganymed Robotics Orthopedics for visionaries There are more and more humans. More and more of them need surgery. Orthopedics especially is driven primarily by age and weight so... yeah. It's going to be impossible to train as many surgeons, let alone good and experienced ones, as the world needs. So what do we do? Let people die of a fractured hip? We believe technology holds part of the answer. We believe the success or failure of a surgical intervention shouldn't be a direct result of the surgeon's state of mind. We believe it's possible to create tools that will improve both patient … Tags: FrenchTech2030 Type: | 22 | 11 | 11 | 56 |
 | STARTUP CREASPHERE powered by Plug and Play Transforming Healthcare Together Startup Creasphere is the first Health focused innovation program in Munich, established by Roche and Plug and Play in 2018. We believe that young innovative health tech companies hold immense potential and deserve their own dedicated pilot-driven program to accelerate their success. Over a 3-months period, Startup Creasphere provides startups with a platform to cover exactly this need, to receive business development opportunities with leading corporations, capital, mentoring, workshops, office space (optional), and access to our global network. For more information, visit: www.startupcreasphere.com or contact startupcreasphere@pnptc.com. Type: | 13 | 2 | 13 | 11 |
 | G_NIUS [Automatic translation follows] Stimulating digital innovations in health G_NIUS: the national counter that makes life easier and saves time for digital health innovators. G_NIUS is the National Counter for Innovation and Uses in e-Health. It helps you decipher the regulatory framework, identify the main players in the ecosystem and understand the methods of financing and access to the market. You are thus directed towards the right resources and the right contacts to best anticipate the stages of your projects and their developments. Planned by the ministerial roadmap for digital health and accelerated within the framework of France 2030, G_NIUS is … Type: | 29 | 7 | 25 | 1 |
 | Wind Where Entrepreneurs Pioneer the Future. We are a VC built and backed by entrepreneurs. We invest in sustainable change. Our mission: To find, fund, and power European innovators who are shaping the future with solutions that meet humanity’s needs without compromising the planet. Driven by our experience, knowledge, and networks, we strategize, iterate, build, and win. Our results speak volumes. Over the past 10 years, we have helped power over 90 companies, completing 27 succesful exits. We make swift, intuitive decisions, trusting your ideas and ability to drive market disruption with pioneering solutions for a sustainable future. deeptech, early stage, … Type: | 15 | 7 | 7 | 12 |
 | Private Equity Magazine [Automatic translation follows] The monthly publication for private equity professionals Find the latest news for private equity professionals on our website and magazine. Deals, surveys and analyses, with a cumulative audience of over 30,000 readers, Private Equity Magazine has become the reference publication for French and European private equity players for 10 years. Type: | 79 | 15 | 76 | 8 |
 | HEC Alumni The association of all HEC Paris graduates | We SHARE. We DARE. We CARE. Founded in 1883 and with a community of 68,000 @HEC Paris graduates worldwide, HEC Alumni has been named the most influential alumni association in the world by The Economist. It federates a network of nearly 1,200 volunteers, more than 100 Clubs, 75 Chapters and initiates 1,000 events each year. HEC Alumni's mission is to inspire and animate its alumni community to contribute to a more inclusive, prosperous and sustainable world. We SHARE. We share, grow and create memories together. We DARE. We dare with our vision … Type: | 56 | 4 | 52 | 107 |
 | Orano Med Innovative targeted alpha therapy to fight cancer using lead-212 (Pb-212) Based on an R&D program started in 2005, Orano Med has developed new processes for producing high-purity lead-212 (Pb-212), a rare radioactive isotope. Lead-212 is currently at the heart of promising projects in nuclear medicine to develop new treatments against cancer. The innovative approach, known as targeted alpha therapy (TAT), recognizes and destroys cancer cells while limiting the impact on nearby healthy cells. Macrocyclics, Inc., an Orano Med company, is the global leader in high performance chelating agent technology, offering a broad range of services and products. For more information … Type: | 7 | 2 | 7 | 140 |
 | Innovation Forum We drive innovative technology development by connecting innovators, industry, and investors. The Innovation Forum is an international grassroots network that supports scientific entrepreneurs aiming to build ambitious companies at the intersection of science, technology and health. Their IMAGINE IF! initiative is a leading pre-acceleration programme for early-stage science-based ventures providing start-ups with extensive opportunities to take their venture to the next level through structured interactions with key stakeholders, tailored expert mentoring and connections with other founders and companies. Global branches: - UK: Cambridge, Oxford, London, Manchester - US: New York City - Switzerland: Lausanne - Spain: Barcelona - Serbia: Belgrade … Type: | 21 | 4 | 16 | 53 |
 | BeTomorrow [Automatic translation follows] Build Digital Masterpieces BeTomorrow is a tech and innovation agency of over 90 digital experts specializing in high-stakes projects. Because great visions require exceptional digital achievements, our mission for 20 years has been to build digital masterpieces with our clients that positively mark the world. It has operated as an innovative startup since its creation, benefiting from a free and creative spirit. After multiple successful experiences in developing mobile applications, games and product launches with ambitious partners, BeTomorrow now brings this dynamism to leading national and international companies, including Apple, Suez, SES, Vinci, BETCLIC, HUMENSIS, Atos, Capgemini, … Type: | 58 | 9 | 49 | 96 |
 | Raily Raily App - Meets on the move. Travel with Raily, never journey alone. Find friends and explore striking destinations. Raily App - Meets on the move Raily it’s a AI-based social travel hub (mobile, mixed reality, smartwatches) tailored for travelers. Earn exclusive NFTs and enjoy crypto cashback while connecting with fellow travelers. The AI-concierge guides users towards unforgettable encounters on the move. Raily. Connect, Travel, Friends. AI, XR, MR, TravelTech, Travel, Social, and Meetups Type: | 18 | 0 | 18 | 15 |
 | redalpine #empoweringGameChangers redalpine is the Swiss venture capital firm that empowers GameChangers. Founded in 2006, redalpine brings together financial investment, operational expertise, and a vast international network to help ambitious entrepreneurs transform their vision into a reality. With over €1bn in assets under management and a disciplined, sector-agnostic investment strategy, the firm has backed some of Europe’s most disruptive companies, including N26, Taxfix, Inkitt, 9fin, Carvolution, Zenjob, vivenu, and Umiami. redalpine has over 95 companies in its portfolio and invests Europe-wide from its offices in Zurich and Berlin. Venture Capital, Startup Financing, Internet, and Life Science Type: | 12 | 4 | 7 | 46 |
 | DealMatrix TRANSACTIONS MADE EASY DealMatrix is a valuation engine that enables startups and investors to quickly and precisely calculate the value of their companies based on various valuation methods, map it against peers, and generate professional reports based on the findings. Investments, Startups, Due Diligence, Business Angels, Venture Capital, Corporate Scouting, Valuation, Investor, Venture Investor, Founder, and Matching | 40 | 0 | 39 | 7 |
 | European Circular Bioeconomy Fund (ECBF) A prosperous economy realigned with nature ECBF is a growth-stage venture capital fund established in Luxembourg dedicated to growth-stage investments within the European Circular Bioeconomy. We bring Europe's circular technologies to market, identifying the most promising investment targets, and syndicating with private and public investors to join financial rounds. Our mission is to provide access to finance to innovative solutions that enable the transitioning from a linear economy to a more sustainable circular one, having the European Investment Bank as a cornerstone investor. Our targeted investment sectors include new technologies and business models in Agtech; blue economy; and bio-based chemicals, … Type: | 16 | 7 | 9 | 32 |
 | La Financière de l'Echiquier Notre métier depuis 1991 : Investisseurs en entreprises Created in 1991, La Financière de l’Echiquier (LFDE) is one of France’s leading boutique asset management companies, with over €12billion in assets under management and a team of more than 130 employees. LFDE relies on its conviction-based management know-how to offer its institutional, distributor and private clients the responsible products and solutions they need to enhance their investments. LFDE is a subsidiary of the Primonial group, independent leader in France in the design, management and advice of investment solutions, and is also present in Switzerland, Italy, Germany, Austria, Spain and the Benelux … | 31 | 8 | 18 | 203 |
 | European Investment Fund (EIF) Mobilising finance for Europe's startups and scaleups. Part of the EIB Group. #ETCI #InvestEU #eif4smes #believeinsmall Part of the EIB Group, the mission of the European Investment Fund (EIF) is to improve access to finance for SMEs and small mid-caps in Europe. We do this by supporting emerging and established fund managers with equity investments and by designing debt financing instruments that share the risk taken by financial institutions when they lend to or invest in small businesses. We bring this support closer to entrepreneurs through our extensive network of partners and financial intermediaries in all EU Member States and … Type: | 38 | 31 | 5 | 683 |
 | Germitec Fast, chemical-free, one-button UV-C high-level disinfection (HLD) for ultrasound probes. A world innovator in UV-C high-level disinfection (HLD) for reprocessing non-lumen medical devices, Germitec is committed to developing, manufacturing, and commercializing HLD devices that radically simplify the work of healthcare professionals, and make examination settings safer, faster, traceable, and chemical-free. ultrasound, disinfection, highleveldisinfection, infectioncontrol, ultraviolet, UVC, désinfection, HLD, transducers, HPV, hightech, medtech, greentech, cleantech, frenchtech, healthtech, and innovation Type: | 11 | 5 | 6 | 62 |
 | Webcapitalriesgo.com [Automatic translation follows] Webcapitalriesgo.com is an initiative that aims to contribute to transparency in the activity of Private Equity, Expansion and Venture Capital, Business Angels) in Spain. The germ of the project is in the research carried out since 1984 by José Martí Pellón, professor at the Complutense University of Madrid. In order to respond to the greatest challenges of information and the growth of the sector, www.webcapitalriesgo.com was created in 2000 to optimize both the acquisition and the dissemination of content on this financial activity. We are in contact with more than 200 investors of various types and sizes … Type: | 22 | 1 | 20 | 2 |
 | Thuja Capital Healthcare Investors Thuja Capital is an early-stage venture capital firm located in Utrecht, The Netherlands. We invest in product focused companies that aim to have true impact for patients and doctors alike, as demonstrated in clinical studies to enable a health claim. Hence most of our ventures are active in the field of therapeutics, medical devices and digital health. Not only do we invest, we also take an active role in helping the company to become successful, by leveraging our extensive network and by bringing our own experience to the table. red biotechnology, life sciences, medical technology, diagnostics, medical devices, … Type: | 10 | 2 | 9 | 18 |
 | EVERSANA EVERSANA® is a leading independent provider of global services to the life sciences industry. The company’s integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 650 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world. To learn more about EVERSANA, visit eversana.com. Regulatory, Management & Specialty Consulting, Research & Insights, Global Pricing Strategies, Patient, Payer & Provider Marketing Services, Field Medical, Market Access & Sales , Global … Type: | 4 | 1 | 0 | 4,442 |
 | IMBC [Automatic translation follows] Financial partner of SMEs IMBC (Invest Mons-Borinage-Centre) is a private law player active in high-end financing (risk capital) and support for SMEs, start-ups, spin-outs and spin-offs. IMBC offers financing solutions adapted to the needs of businesses at any stage of their life: from creation to transfer. Active for more than 30 years, the Group has intervened for the benefit of more than 1,225 companies, including 350 still in its portfolio. Venture capital, SME, Start-ups, Investments, Loan, Risk investments, Equity, Investment facilitation, Spin-off, Entrepreneurship, Family business, Growth, Innovation, Success story, Enterprise, Funding, and Wallonia Type: | 14 | 2 | 13 | 18 |
 | SFPIM Federal Holding and Investment Company (Federale Participatie- en Investeringsmaatschappij / Société Fédérale de Participations et d'Investissement) was created on 1 November 2006 as a result of the merger between the Federal Participation Company and the Federal Investment Company, two public holding companies that each have their own history. The federal government is the sole shareholder in the Federal Holding and Investment Company. The Federal Holding and Investment Company (FHIC) centrally manages the federal government's shareholdings, cooperates with the government on specific projects and pursues its own investment policy in the interests of the Belgian economy. The FHIC has three core … | 17 | 7 | 10 | 52 |
 | Talent4Boards Inc. Great Talent builds Great Boards Talent4BoardsTM is a global Board news and publishing portal that focuses on Board visibility for public companies as well as VC/PE-backed companies. Talent4BoardsTM helps the Board members to shine in the spotlight as we consider them as experts - seasoned, bright, passionate, dedicated, and accountable -, and we support them for that. Talent4BoardsTM network is global and includes both Corporate Directors of Fortune 500 & Global 500 companies as well as those of Unicorns and other Start-ups/Growth companies. With over 10,000 guest members of Boards of Directors in main Stock Markets around the world, our … Type: | 20 | 0 | 20 | 1 |
 | Chiesi Group Chiesi is an international, research-focused biopharmaceuticals group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment. By changing its legal status to a Benefit Corporation in Italy, the US, and France, Chiesi’s commitment to create shared value for society as a whole is legally binding and central to company-wide decision-making. As a certified B Corp since 2019, we’re part of a global community of businesses that meet high standards of social and environmental impact. … Type: | 12 | 3 | 7 | 5,431 |
 | Sygnature Discovery Sygnature Discovery is a world-leading integrated drug discovery Contract Research Organisation, with over 1000 staff from 53 nationalities, including 900 scientists working on drug discovery programmes. Founded in 2004, we have delivered over 40 pre-clinical compounds, 21 clinical compounds, and our scientists are named on over 170 patent applications. We partner with global pharma, biotech, and NFP organizations, providing integrated drug discovery services from target identification through to candidate nomination. Our co-located teams are experts in protein science, chemistry, computational chemistry, in vitro biology, pharmacology, DMPK, form and formulation services, and project management, with a core therapeutic focus on oncology, … Type: | 9 | 0 | 6 | 673 |
 | Shorla Oncology At Shorla Oncology we develop and commercialize innovative oncology medicines for women’s and pediatric cancers. At Shorla Oncology we develop and commercialize innovative oncology drugs. We focus on indications where existing treatments are limited, in shortage or inadequate for the target population. Our products are the result of Shorla’s world class team encompassing thought leaders, clinicians, scientists and commercial strategists who have extensive experience in the area of drug development and commercialization of niche cancer treatments. Our growing portfolio will bring accessible, affordable and life-saving treatments to patients, delivering a major contribution to patient care and providing a significant clinical … Type: | 4 | 2 | 1 | 28 |
 | Earlybird Venture Capital Earlybird is a venture capital investor focused on European technology companies Earlybird Venture Capital focuses on European technology companies. Founded in 1997, Earlybird identifies and backs exceptional early-stage companies on a pan-European basis and supports them through their growth and development phases – providing financial resources, strategic support, and access to an international network & capital markets. Earlybird invests out of a family of independently-managed funds. Flagship funds with early-stage focus include Digital West (Western Europe), Digital East (Emerging Europe), and Health. Newer funds Earlybird-X (pre-seed in Western Europe & university spinoffs) and Growth Opportunities (a pan-Earlybird growth fund) offer … Type: | 50 | 22 | 32 | 141 |
 | Pureos Bioventures Pureos is a venture capital fund investing in private innovative drug development companies Pureos Bioventures is a venture capital fund, which invests exclusively in private innovative drug development companies, with a special emphasis on the next generation of biological drugs and drug formats. The fund’s portfolio companies are built on scientific excellence to develop therapies across a broad indication spectrum including oncology, immunology, ophthalmology, rare diseases, and neuroscience. Pureos has built a team with deep investment, operating and clinical expertise, that strives to impact patients’ lives by advancing innovative treatments for devastating diseases. Type: | 4 | 1 | 3 | 14 |
 | MIG Capital Together, we build companies that move the world forward. MIG Capital is one of the leading German early-stage VC investors. We turn vision into value by providing financing to young innovative companies in Life Science and Deep Tech across Europe. Since our beginnings in 2004, we have invested more than €650 million in ~50 companies. Today, our portfolio consists of 30 groundbreaking companies. Venture capital, Entrepreneurship, Deep tech, Life sciences, and Private equity Type: | 14 | 5 | 11 | 27 |
 | Forbion Impacting the future of medicine Forbion was born out of ABN AMRO Capital Life Sciences in 2000. Six years later, we transitioned to Forbion Capital Partners. Today, to emphasize our value-add beyond merely providing capital, we are simply known as Forbion. For more than two decades, our investment team has built an impressive track record of sourcing, building and guiding life-sciences companies resulting in many breakthrough therapies and valuable exits. Forbion currently manages over €2.3 bn across ten funds. As of October 2022, Forbion holds 43 active portfolio companies bringing its investments to 95 companies to date with 46 employees. … Type: | 8 | 4 | 5 | 62 |
 | Tiendanimal [Automatic translation follows] Tiendanimal was founded in Malaga in 2006 as an online company, with the aim of improving the shopping experience of people with pets in their family 🏠 and offering excellent quality products. We currently have more than 100 physical stores throughout Spain and Portugal. We offer our customers the best service to meet all their needs. Are you coming to visit us? 🐱🐶 We will be happy to assist you! We offer a wide variety of products from major brands, as well as having our own manufacturing and exclusive sales brands! We also have services for all … | 7 | 0 | 2 | 551 |
 | Heal Capital One of Europe’s leading dedicated venture capital funds for integrated HealthTech. We reimagine healthcare by leveraging cutting-edge technology to make a difference in people‘s lives. Heal Capital is one of Europe’s leading dedicated investment funds for integrated HealthTech with a total investment volume of EUR 100m, backed by the German private health insurers. We back mission-driven founders with capital and HealthTech-specific expertise, accelerating market access to the healthcare system. Register to our newsletter to receive the lastest information on our events in your mailbox! https://healcapital.typeform.com/to/tnypj2L8 Type: | 7 | 6 | 1 | 14 |
 | Almi [Automatic translation follows] We invest in future growth - business loans, venture capital and business development for companies that want to grow! Almi's job is to nurture you, so you and your business can grow and flourish. Our job is to support and coach you. Our job is to offer expertise when you need it and fill the gaps in the market. We offer financing in the form of loans and risk capital as well as support and guidance in business development. Because all companies with potential should be given the same opportunities. Or as we put it: Nutrition, which … Type: | 9 | 3 | 4 | 39 |
Large company